CARDIOPROGRESS
Foundation for the advancement of cardiology

Influencers of COVID Vaccine Response in Dialysis Patients Among patients undergoing maintenance dialysis, chronic heart failure and hypoalbuminaemia were significantly associated with a poor humoral response at 3 months after completing three doses of the SARS-CoV-2 messenger RNA (mRNA) vaccine; however, no association was observed between haemodialysis-related variables and antibody response levels.

Fewer ECG Abnormalities in Early T2D With Combo Therapy In patients with type 2 diabetes (T2D) of less than 10 years' duration who were taking metformin monotherapy, ECG abnormalities — including evidence of cardiovascular autonomic neuropathy — were common and associated with cardiovascular risk factors. After adding one of four frequently used glucose-lowering agents to metformin, fewer major ECG changes occurred with liraglutide than with the other treatments.

Surgery Treats Hypertension in Patients With Adrenal Tumours In patients with unilateral adrenal incidentalomas and mild autonomous cortisol secretion (MACS), adrenalectomy was well tolerated and enabled a reduction or cessation of hypertensive treatment while maintaining blood pressure within normal ranges.

Acute Myocarditis Riskier Than Unexplained Chest Pain Despite being younger and having fewer comorbidities, patients with acute myocarditis (AM) had a significantly higher risk for 30-day and long-term mortality than those with unexplained chest pain.

Effect of BMI on Cardiovascular Risk in Rheumatoid Arthritis Varies by Antibody Status and Biologic Use Body mass index (BMI) influenced cardiovascular risk in rheumatoid arthritis (RA), with the effects varying according to anti–citrullinated protein antibody (ACPA) status and use of biologics. BMI was inversely associated with lower cardiovascular risk in ACPA-negative patients on biologics.

Sleep Disorders Linked to Aortic Stenosis Having any sleep disorder was independently linked to a higher likelihood for developing aortic stenosis, although dyslipidemia appeared to be an important mediator of the risk.

Age of menopause, healthy lifestyle and cardiovascular disease in women: a prospective cohort study Menopause is a timely opportunity to screen for cardiovascular disease (CVD) and intervene with healthier lifestyles. Scientists investigated the association between premature/early menopause and the likelihood of CVD and whether a healthy lifestyle is associated with a lower likelihood of CVD in menopausal woman.

Few Women Screened for Diabetes, Dyslipidemia Postpartum Screening for cardiovascular risk factors after pregnancy-related hypertension or diabetes may be suboptimal during the year after giving birth, data indicated.

Right ventricular remodelling and long-term survival after pulmonary endarterectomy versus balloon pulmonary angioplasty in chronic thromboembolic pulmonary hypertension Pulmonary endarterectomy (PEA) is the treatment of choice for chronic thromboembolic pulmonary hypertension (CTEPH), while balloon pulmonary angioplasty (BPA) is an alternative for inoperable patients. We aimed to compare right ventricular (RV) remodelling and late survival after PEA and BPA.

Association between NT-proBNP levels and risk of atrial fibrillation: a systematic review and meta-analysis of cohort studies N-terminal pro-B-type natriuretic peptide (NT-proBNP) is a well-established biomarker in clinical practice, particularly for heart failure, but its role in predicting atrial fibrillation (AF) risk is not fully understood. This meta-analysis aimed to evaluate the association between NT-proBNP levels and AF incidence, and to explore the potential of NT-proBNP in enhancing AF risk prediction models.

Guideline for the Evaluation and Management of Acute Pulmonary Embolism in Adults in 2026 The 2026 Guidelines for the Evaluation and Management of Acute Pulmonary Embolism in Adults, developed by the American Heart Association, the American College of Cardiology, the American College of Chest Physicians, the American College of Embolology et al.

Guideline on the Management of Dyslipidemia The new 2026 ACC/AHA/AACVPR et al. Guidelines for the Management of Dyslipidemia have been published. These guidelines address the assessment, treatment, and monitoring of individuals with dyslipidemia, including high blood cholesterol, elevated triglycerides, and elevated lipoprotein(a) [Lp(a)]. These new guidelines address primary, secondary, and primary prevention, provide guidance for care of adults and children, reinstate risk-based treatment targets for low-density lipoprotein (LDL) cholesterol, and replace the 2018 AHA/ACC/Multisociety Cholesterol Treatment Guidelines.

Development and validation of a machine learning model to predict myocardial blood flow and clinical outcomes from patients’ electrocardiograms Scientists have developed a machine learning (ML) model using electrocardiography (ECG) to predict myocardial blood flow reserve (MFR) and assess its predictive value in relation to major adverse cardiovascular events (MACEs). Using 3639 ECG positron emission tomography (PET) and 17,649 pairs of ECG single-photon emission computed tomography data (SPECT), the model is trained using the intelligent swarm intelligence approach and support vector regression (SVR).

New Scanner Creates Highly Detailed, 3D Images of Blood Vessels in Just Seconds A new scanner can provide three-dimensional (3D) photoacoustic images of millimeter-scale veins and arteries in seconds.

Nobel Prize in medicine goes to two American biologists for work on the discovery of microRNA The 2024 Nobel Prize in physiology or medicine has been awarded to US scientists Victor Ambros and Gary Ruvkun for their work on the discovery of microRNA, a molecule that governs how cells in the body function.

Diabetes mellitus has been completely cured for the first time in the world For the first time, scientists transplanted stem cells into a woman with type 1 diabetes, after which she began to produce her own insulin. This is the world's first case of treatment using cells taken from the patient's body.

New Hypertension Approach Hits Multiple Targets at Low Dose Single-pill combinations that include three or four antihypertensive medications are the way forward for the management of patients with elevated blood pressure, according to experts evaluating the new approach.

Emerging role of incretin-based therapy as first-line antihypertensives in obesity Obesity is a major global health issue and a leading cause of premature death. The prevalence of obesity has been rising faster than most other known modifiable risk factors. In a Global Burden of Disease analysis, the prevalence of obesity was found to have doubled in more than 70 countries from 1980 to 2013.

A new app uses smartphone technology to 'uncuff' blood pressure monitoring Researchers at the University of Pittsburgh are pioneering a new approach to blood pressure monitoring—using the devices we carry with us every day.

New Blood Pressure Guidelines Lower Treatment Target Simplified and more aggressive targets are among the significant changes to the updated hypertension guidelines released by the European Society of Cardiology.